1. Home
  2. RNXT vs DVLT Comparison

RNXT vs DVLT Comparison

Compare RNXT & DVLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • DVLT
  • Stock Information
  • Founded
  • RNXT 2012
  • DVLT 2010
  • Country
  • RNXT United States
  • DVLT United States
  • Employees
  • RNXT N/A
  • DVLT N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • DVLT
  • Sector
  • RNXT Health Care
  • DVLT
  • Exchange
  • RNXT Nasdaq
  • DVLT NYSE
  • Market Cap
  • RNXT 44.6M
  • DVLT 57.0M
  • IPO Year
  • RNXT 2021
  • DVLT N/A
  • Fundamental
  • Price
  • RNXT $1.40
  • DVLT $0.82
  • Analyst Decision
  • RNXT Strong Buy
  • DVLT
  • Analyst Count
  • RNXT 2
  • DVLT 0
  • Target Price
  • RNXT $7.00
  • DVLT N/A
  • AVG Volume (30 Days)
  • RNXT 210.6K
  • DVLT 727.3K
  • Earning Date
  • RNXT 05-15-2025
  • DVLT 06-06-2025
  • Dividend Yield
  • RNXT N/A
  • DVLT N/A
  • EPS Growth
  • RNXT N/A
  • DVLT N/A
  • EPS
  • RNXT N/A
  • DVLT N/A
  • Revenue
  • RNXT $240,000.00
  • DVLT $3,048,000.00
  • Revenue This Year
  • RNXT $3,927.91
  • DVLT $434.03
  • Revenue Next Year
  • RNXT $219.75
  • DVLT $185.71
  • P/E Ratio
  • RNXT N/A
  • DVLT N/A
  • Revenue Growth
  • RNXT N/A
  • DVLT 63.08
  • 52 Week Low
  • RNXT $0.75
  • DVLT $0.60
  • 52 Week High
  • RNXT $1.69
  • DVLT $3.78
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 78.13
  • DVLT N/A
  • Support Level
  • RNXT $1.17
  • DVLT N/A
  • Resistance Level
  • RNXT $1.30
  • DVLT N/A
  • Average True Range (ATR)
  • RNXT 0.08
  • DVLT 0.00
  • MACD
  • RNXT 0.02
  • DVLT 0.00
  • Stochastic Oscillator
  • RNXT 100.00
  • DVLT 0.00

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About DVLT DATAVAULT AI INC

Datavault AI Inc is a data technology and licensing company that enables clients and strategic partners to monetize their Blockchain Data and AI Web 3.0 assets via tokenization, data ownership and digital twins offering two solutions: Data Science licenses High-Performance Computing (HPC) software applications and Web 3.0 data management serving the biotech, energy, education, fintech, real estate, and healthcare industries, among others. Acoustic Science licenses spatial and multichannel HD sound transmission, including proprietary brands ADIO, WiSA and Sumerian, to customers in sports & entertainment, events & venues, restaurants, automotive, finance, and other industries.

Share on Social Networks: